Preparation method and application of exosome loaded with 4-octyllipoitaconic acid
By using the phospholipid bilayer structure of the exosome to load 4-octanoitaconic acid, the problem of low efficiency and toxic cosolvent in vivo applications is solved, and efficient anti-inflammatory delivery and therapeutic effects are achieved.
Patent Information
- Application Number
- CN202411002792.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-08
AI Technical Summary
4-The fat-soluble and poor water-soluble of 4-Pinetic Itaconic acid has high fat-soluble properties, resulting in the need of high toxic cosolvents when used in vitro, and the intravenous or oral administration is inefficient and easy to be eliminated, making it difficult to effectively exert anti-inflammatory effects.
Using exosomes as carrier, 4-octanoitacacic acid is loaded through specific solution treatment and incubation steps, and 4-octanoitacic acid is stably wrapped with phospholipid bilayer structure, avoiding the use of cosolvents, and passing through the giant The phagocytic mechanism of phages and endothelial cells delivers it to inflammatory cells.
It effectively improves the drug delivery efficiency of 4-oxanthic acid, ensures that it can enter cells stably and exerts an anti-inflammatory effect, avoids the risk of toxicity of the co-solvent, and improves the anti-inflammatory treatment effect.
Smart Images

Figure CN118909920A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biotechnology, and in particular to a preparation method and application of exosomes loaded with 4-octylitaconic acid. Background Art
[0002] Itaconic acid, as a metabolite of the body, has good anti-inflammatory ability, but due to its relatively active chemical properties and good water solubility, it is difficult to enter and exit the cell membrane. However, its derivative 4-OI (4-octyl itaconic acid) is more stable, has high lipid solubility, can freely enter and exit the cell membrane, and can be hydrolyzed into itaconic acid after entering the cell, playing the same role as itaconic acid. However, 4OI has high lipid solubility and poor water solubility, so it requires cosolvents such as Tween and DMSO. However, if used in vivo, cosolvents have certain toxicity, and its intravenous or oral administration efficiency is relatively low, and it is easily eliminated.
[0003] Exosomes are nanoscale vesicles with a diameter of 30-200nm secreted by living cells. They are extracellular vesicles containing a phospholipid bilayer and are rich in biologically active molecules such as proteins, nucleic acids, and lipids. They are naturally non-toxic and harmless. They are widely distributed in various body fluids such as blood, urine, milk, and bile. They can be phagocytosed by cells related to inflammation and oxidative stress, such as macrophages and endothelial cells, and can effectively deliver the anti-inflammatory substance itaconic acid to inflammatory cells to exert a therapeutic effect. Summary of the invention
[0004] The object of the present invention is to provide a method for preparing exosomes loaded with 4-octylitaconic acid to solve the problems raised in the background technology.
[0005] To achieve the above object, the present invention provides the following technical solution: A method for preparing exosomes loaded with 4-octylitaconic acid comprises the following steps:
[0006] S1, dissolving 4-octyl itaconic acid in DMSO solution, and diluting with deionized water in a gradient manner to obtain a 4-octyl itaconic acid solution;
[0007] S2, dissolving the exosomes in a phosphate buffered saline solution (PBS solution) to obtain an exosome solution;
[0008] S3. Add the 4-octyl-itaconic acid solution to the exosome solution, incubate at 37°C for 60 min, cool to 4°C, stand for 60 min, remove the supernatant by ultracentrifugation, collect the precipitate, and resuspend it with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0009] Furthermore: the concentration of the 4-octylitaconic acid solution in step S1 is 20-200 μM.
[0010] Furthermore: the exosomes in step S2 are commercialized exosomes of 293F cells.
[0011] Furthermore: the pH of the PBS solution in step S2 is 7.2-7.4.
[0012] Further: the density of exosomes in the exosome solution in step S2 is 10 11 / mL.
[0013] Further: the container for incubation in step S3 is a 1.5 mL EP tube.
[0014] Furthermore: the centrifugal force of the ultracentrifugation in step S3 is 100000g, the temperature is 4°C, and the time is 70min.
[0015] Furthermore: the pH of the PBS solution in step S3 is 7.2-7.4.
[0016] Furthermore: in step S3, the volume ratio of the 4-octylitaconic acid solution to the exosome solution is 1:1.
[0017] Compared with the prior art, the present invention has the following beneficial effects: the itaconic acid derivative 4-octylitaconic acid (4-OI) overcomes the shortcomings of itaconic acid that itaconic acid is highly polar and difficult to penetrate the cell membrane. Itaconic acid and 4-OI have similar thiol reactivity, but 4-OI is highly lipid-soluble and can freely enter and exit the cell membrane. After entering the cell, it can be hydrolyzed into itaconic acid and exert the same effect as itaconic acid; the exosomes have a phospholipid bilayer, which can load the lipophilic 4-OI and maintain its stability, avoiding the use of cosolvents such as Tween and DMSO. When used in vivo, the cosolvents have certain toxicity, and the efficiency of intravenous or oral administration is low. The exosomes loaded with 4-OI can be phagocytosed by cells related to inflammation and oxidative stress such as macrophages and endothelial cells, and can effectively deliver the anti-inflammatory substance itaconic acid it carries to inflammatory cells, exerting the effect of treating inflammation and ensuring the efficiency of administration. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 This is an electron microscope image of exosomes loaded with 4-OI (the white disks are exosomes).
[0019] Figure 2 Electron microscopy images of exosomes without 4-OI loading.
[0020] Figure 3 is the particle size of exosomes before loading with 4-OI.
[0021] Figure 4 is the particle size of exosomes after loading with 4-OI.
[0022] Figure 5 The exosome loading rate and loading concentration corresponding to different concentrations of 4-OI. DETAILED DESCRIPTION
[0023] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.
[0024] The present invention provides a technical solution: a method for preparing exosomes loaded with 4-octylitaconic acid.
[0025] Preparation of 4-octyl itaconic acid solution:
[0026] 1 mg of 4-octyl itaconic acid was dissolved in 4.1269 mL of DMSO solution to obtain a 4-octyl itaconic acid solution (1 mM). Deionized water was used to dilute the solution in proportion to obtain 1 mL of each of 250 μM, 200 μM, 150 μM, 100 μM, 80 μM, 40 μM, and 20 μM 4-octyl itaconic acid solutions.
[0027] Exosome solution preparation:
[0028] 10 11 Exosomes were dissolved in 1 mL of PBS solution to obtain an exosome solution.
[0029] Example 1
[0030] 200 μL (100 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0031] Example 2
[0032] 200 μL (20 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0033] Example 3
[0034] 200 μL (40 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0035] Example 4
[0036] 200 μL (80 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0037] Example 5
[0038] 200 μL (150 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0039] Example 6
[0040] 200 μL (200 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, and the precipitate was collected and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0041] Example 7
[0042] 200 μL (250 μM) 4-octyl-itaconic acid solution was added to 200 μL exosome solution, incubated at 37°C for 60 min, cooled to 4°C, allowed to stand for 60 min, ultracentrifuged to remove the supernatant, the precipitate was collected, and resuspended with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
[0043] Analytical experiments: NTA and TEM were used to detect the morphology and particle size of exosomes before and after 4-OI treatment, and LC / MS was used to detect the concentration of 4OI entering the exosomes to detect the loading rate of 4-OI.
[0044] Analysis shows that: according to Figure 1 and Figure 2 It can be seen that after co-incubation, 4-OI can be loaded into exosomes, and the morphology of exosomes has not changed significantly. Figure 3 and Figure 4 It can be seen that the exosome particle size is slightly larger before and after loading. Figure 5 It can be concluded that when the concentration of 4-OI is 100 μM, the loading rate of exosomes is the highest, and 4-OI can be effectively loaded, further delivering anti-inflammatory substances to inflammatory cells, thereby exerting an inflammatory treatment effect.
[0045] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for preparing exosomes loaded with 4-octylitaconic acid, characterized in that: The following steps are involved: S1, dissolving 4-octyl itaconic acid in DMSO, and then diluting it in a gradient manner with deionized water to obtain a 4-octyl itaconic acid solution; S2, dissolving the exosomes in a PBS solution to obtain an exosome solution; S3. Add the 4-octyl-itaconic acid solution to the exosome solution, incubate at 37°C for 60 min, cool to 4°C, stand for 60 min, remove the supernatant by ultracentrifugation, collect the precipitate, and resuspend it with PBS solution to obtain exosomes loaded with 4-octyl-itaconic acid.
2. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The concentration of the 4-octylitaconic acid solution in step S1 is 20-200 μM.
3. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The exosomes in step S2 are commercially available exosomes from 293F cells.
4. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The pH of the PBS solution in step S2 is 7.2-7.
4.
5. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The density of exosomes in the exosome solution in step S2 is 10 11 Pieces / mL.
6. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The container for incubation in step S3 is a 1.5 mL EP tube.
7. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The centrifugal force of the ultracentrifugation in step S3 is 100000 g, the temperature is 4° C., and the time is 70 min.
8. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: The pH of the PBS solution in step S3 is 7.2-7.
4.
9. The method for preparing exosomes loaded with 4-octylitaconic acid according to claim 1, characterized in that: In step S3, the volume ratio of the 4-octylitaconic acid solution to the exosome solution is 1:
1.
10. Use of the method for preparing exosomes loaded with 4-octylitaconic acid as claimed in any one of claims 1 to 9 in anti-inflammatory drug preparations.
